Preface

The field of Hematology is changing in many exciting ways. Since our time in training, we have seen the advent of new direct oral anticoagulants, targeted therapies in chronic myelogenous leukemia and B-cell lymphomas, and long-acting (and soon even longer duration) factor replacement in hemophilia. We have also seen improved risk stratification, maturing of reduced intensity and haploidentical stem-cell transplant, and the rebirth of gene therapy. These are changes that have improved the quality of life and survival of our patients.
Source: Primary Care: Clinics in Office Practice - Category: Primary Care Authors: Source Type: research